Product NDC: | 67457-187 |
Proprietary Name: | Aloprim |
Non Proprietary Name: | Allopurinol |
Active Ingredient(s): | 500 mg/25mL & nbsp; Allopurinol |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-187 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020298 |
Marketing Category: | NDA |
Start Marketing Date: | 19960501 |
Package NDC: | 67457-187-50 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-187-50) > 25 mL in 1 VIAL, GLASS |
NDC Code | 67457-187-50 |
Proprietary Name | Aloprim |
Package Description | 1 VIAL, GLASS in 1 CARTON (67457-187-50) > 25 mL in 1 VIAL, GLASS |
Product NDC | 67457-187 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Allopurinol |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960501 |
Marketing Category Name | NDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | ALLOPURINOL |
Strength Number | 500 |
Strength Unit | mg/25mL |
Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |